https://www.buffalo.edu/ubreporter/archive/vol30/vol30n35/n6.html
22 Jul 1999:
in the Department of Immunology at RPCI; Charles Arntzen, president and CEO of BTI and adjunct professor of biological sciences at Cornell University, and Hugh Mason, BTI assistant research scientist and